A nano-system combines mitochondrial damage with microtubule stabilization for cancer metastasis suppression

Area of Science:

• Oncology
• Nanotechnology
• Cell Biology

Background:

• Mitochondria targeting is a known cancer therapy strategy, but alone it shows limited efficacy against metastasis.
• The interplay between mitochondria and microtubules is crucial for cancer cell function and migration.
• Developing effective treatments for cancer metastasis remains a significant clinical challenge.

Purpose of the Study:

• To develop and evaluate an active-targeting nano-system for cancer metastasis treatment.
• To investigate the synergistic effects of combined mitochondrial damage and microtubule stabilization.
• To elucidate the underlying mechanisms of the nano-system's anti-metastasis activity.

Main Methods:

• Formulation of a nano-system co-delivering a mitochondrial-damaging drug and a microtubule stabilizer.
• In vitro assessment of synergistic cytotoxicity, tumor cell migration, and invasion inhibition.
• In vivo evaluation of lung metastasis suppression in preclinical models.
• Mechanistic studies involving reactive oxygen species, adenosine triphosphate levels, mitochondrial dynamics, and epithelial-mesenchymal transition markers.

Main Results:

• The nano-system demonstrated synergistic cytotoxicity against cancer cells in vitro.
• Significant inhibition of tumor cell migration and invasion was observed compared to single-agent treatments.
• In vivo studies showed over 85% suppression of lung metastasis.
• The nano-system induced mitochondrial damage via increased reactive oxygen species and decreased adenosine triphosphate, while microtubule stabilization suppressed mitochondrial fission.

Conclusions:

• Combined mitochondrial damage and microtubule stabilization via a nano-system offers a potent strategy against cancer metastasis.
• The nano-system effectively suppresses tumor cell migration and invasion by targeting mitochondrial function and microtubule dynamics.
• This combination therapy presents a promising approach for managing and treating metastatic cancers.